Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Versant Venture Management

Versant Venture Management
VC INVESTOR TYPE
Active STATUS
26 PROFESSIONALS
407 INVESTMENTS
67 PORTFOLIO
155 EXITS
Description

Versant Ventures is a leading healthcare investment firm committed to helping entrepreneurs build the next generation of great companies. The firm's emphasis is on biotechnology companies that are discovering and developing novel therapeutics. With $3 billion under management and offices in the U.S., Canada and Europe, Versant has built a team with deep investment, operating and clinical expertise that enables a hands-on approach to company building. Since the firm's founding in 1999, more than 70 Versant companies have achieved successful acquisitions or IPOs.

Investor Status
Actively Seeking New Investments
Trade Association
National Venture Capital Association (NVCA)
Year Founded
1999
Primary Investor Type
Venture Capital
Other Investor Types
Accelerator/Incubator
Primary Office
  • One Sansome Street
  • Suite 3630
  • San Francisco, CA 94104
  • United States

+1 (415) 000-0000

Versant Venture Management Investments (407)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Vividion Therapeutics 30-Apr-2019 Early Stage VC 0000 Biotechnology Startup 000000 0000000 00.0
00000 000000000000 19-Mar-2019 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 3 00000 00000 00
000000 00000 00000 14-Feb-2019 00000 00000 0000 Drug Discovery Clinical Trials - Phase 3 0000000 0000 00.0
0000000 000 14-Feb-2019 00000 00000 00000 Other Healthcare Services Generating Revenue 000000 0000000 00.0
0000000 11-Feb-2019 00000 00000 0000 Other Healthcare Technology Systems Clinical Trials - Phase 1 0000 0000000
000000000 30-Jan-2019 00000 00000 00000 Building Products Generating Revenue 000000 0000000
00000 0000000 0000 09-Jan-2019 00000 00000 0000 Biotechnology Product Development 000000000 000000 00.0
00000 000000000000 12-Dec-2018 00000 00000 0000 Biotechnology Startup 000000 00000000 00.0
Black Diamond Therapeutics 11-Dec-2018 Early Stage VC 0000 Biotechnology Product Development 000000000 000000 00.0
Gotham Therapeutics 10-Oct-2018 Early Stage VC 0000 Drug Discovery Startup 00000 0000000 00.0
To view this investor’s complete investment and acquisition history, request access »
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Versant Venture Management’s full profile, request a free trial.

Versant Venture Management Exits (152)

Company Name Exit Date Exit Type Exit Size Status Buyers
Achaogen 15-Apr-2019 Bankruptcy: Admin/Reorg Completed
0000000 0000000000 22-Jan-2019 000000000000000000 00000 Completed
  • 00000 & 000000
000000000 0 05-Nov-2018 000000000000000000 Completed
  • 0000000000
00000000 17-Oct-2018 000000000000000000 00000 Completed
  • 000000 0000000000
000000000 00000000 28-Sep-2018 000 00000 Completed
000000000 00000000 18-Jul-2018 000 00000 Completed
0000000000 0000000 09-Jul-2018 000000000000000000 Completed
  • 00000000
00000000 000000 30-Apr-2018 0000000000 00000 Completed
  • 2 buyers
OpGen 26-Apr-2018 Secondary Transaction - Open Market Completed
Inception 5 04-Apr-2018 Merger/Acquisition Completed
To view this investor’s complete exits history, request access »

Versant Venture Management Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is reserved for PitchBook Platform accredited users. To explore Versant Venture Management‘s full profile, request access.

Request full access to PitchBook

Versant Venture Management Team (59)

Name Title Deals Funds Boards Office Contact
Info
Robin Praeger Chief Financial Officer & Managing Director 0 San Francisco, CA
Barbara Lubash Co-Founder & Active Managing Director Of Earlier Funds 00 0 0 Newport Beach, CA
Donald Milder Co-Founder & Active Managing Director Of Earlier Funds 0 0 0 Newport Beach, CA
Rebecca Robertson Co-Founder & Active Managing Director Of Earlier Funds 00 0 0 San Francisco, CA
Ross Jaffe MD Co-Founder & Active Managing Director Of Earlier Funds 00 0 0 San Francisco, CA

20 Former Team Members

You’re viewing 5 of 59 team members. Get the full list »

Versant Venture Management Co-Investors (153)

Name With Exits Lead Partner
5AM Ventures 6 00
New Enterprise Associates 0 0 00
Alexandria Venture Investments 0 0
OrbiMed 0 0 0
SR One 0 0
To view this investor’s complete co-investor history, request access »